ICD Therapy for the Prevention of Sudden Cardiac Death in Post-MI Patients

Overview

Journal Curr Treat Options Cardiovasc Med

Specialty Cardiology & Vascular Diseases

Date 2003 Aug 28

PMID 12941205

Authors

Stephen J Hahn

Joseph M Smith

Affiliations

Soon will be listed here.

Abstract

Implantable cardioverter-defibrillators (ICDs) are unequivocally the treatment of choice for patients who have already experienced a near-fatal tachyarrhythmic event. Recently, studies have conclusively demonstrated that extending the benefits of ICD therapy to postinfarction patients with resultant left ventricular dysfunction results in dramatic additional lifesaving without the need for complex risk- stratification procedures. The landmark Multicenter Automatic Defibrillator Implantation Trial II (MADIT II) shows that patients with reduced left ventricular function (ejection fraction < 30%) 1 month after a myocardial infarction should receive an ICD to prevent sudden cardiac death.

References

Connolly S, Gent M, Roberts R, Dorian P, Roy D, Sheldon R . Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation. 2000; 101(11):1297-302. DOI: 10.1161/01.cir.101.11.1297. View

BIGGER Jr J, Fleiss J, KLEIGER R, Miller J, Rolnitzky L . The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation. 1984; 69(2):250-8. DOI: 10.1161/01.cir.69.2.250. View

Sim I, McDonald K, Lavori P, Norbutas C, Hlatky M . Quantitative overview of randomized trials of amiodarone to prevent sudden cardiac death. Circulation. 1997; 96(9):2823-9. DOI: 10.1161/01.cir.96.9.2823. View

. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 1997; 337(22):1576-83. DOI: 10.1056/NEJM199711273372202. View

Kuck K, Cappato R, Siebels J, Ruppel R . Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH). Circulation. 2000; 102(7):748-54. DOI: 10.1161/01.cir.102.7.748. View

Naccarelli G, Wolbrette D, DellOrfano J, Patel H, Luck J . A decade of clinical trial developments in postmyocardial infarction, congestive heart failure, and sustained ventricular tachyarrhythmia patients: from CAST to AVID and beyond. Cardiac Arrhythmic Suppression Trial. Antiarrhythmic Versus Implantable.... J Cardiovasc Electrophysiol. 1998; 9(8):864-91. DOI: 10.1111/j.1540-8167.1998.tb00127.x. View

Cairns J, Connolly S, Roberts R, Gent M . Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators. Lancet. 1997; 349(9053):675-82. DOI: 10.1016/s0140-6736(96)08171-8. View

Kupersmith J, Holmes-Rovner M, Hogan A, ROVNER D, Gardiner J . Cost-effectiveness analysis in heart disease, Part III: Ischemia, congestive heart failure, and arrhythmias. Prog Cardiovasc Dis. 1995; 37(5):307-46. DOI: 10.1016/s0033-0620(05)80017-9. View

Moss A, Zareba W, Hall W, Klein H, Wilber D, Cannom D . Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002; 346(12):877-83. DOI: 10.1056/NEJMoa013474. View

10.

Echt D, Liebson P, Mitchell L, Peters R, BARKER A, Arensberg D . Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med. 1991; 324(12):781-8. DOI: 10.1056/NEJM199103213241201. View

11.

Mushlin A, Hall W, Zwanziger J, Gajary E, Andrews M, Marron R . The cost-effectiveness of automatic implantable cardiac defibrillators: results from MADIT. Multicenter Automatic Defibrillator Implantation Trial. Circulation. 1998; 97(21):2129-35. DOI: 10.1161/01.cir.97.21.2129. View

12.

MOSS A, Hall W, Cannom D, Daubert J, Higgins S, Klein H . Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med. 1996; 335(26):1933-40. DOI: 10.1056/NEJM199612263352601. View

13.

Gold M, Shorofsky S, Thompson J, Kim J, Schwartz M, Bocek J . Advanced rhythm discrimination for implantable cardioverter defibrillators using electrogram vector timing and correlation. J Cardiovasc Electrophysiol. 2002; 13(11):1092-7. DOI: 10.1046/j.1540-8167.2002.01092.x. View

14.

Leclercq C, Kass D . Retiming the failing heart: principles and current clinical status of cardiac resynchronization. J Am Coll Cardiol. 2002; 39(2):194-201. DOI: 10.1016/s0735-1097(01)01747-8. View

15.

Buxton A, Lee K, Fisher J, Josephson M, Prystowsky E, Hafley G . A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med. 1999; 341(25):1882-90. DOI: 10.1056/NEJM199912163412503. View

16.

Schaumann A, von zur Muhlen F, Herse B, Gonska B, Kreuzer H . Empirical versus tested antitachycardia pacing in implantable cardioverter defibrillators: a prospective study including 200 patients. Circulation. 1998; 97(1):66-74. DOI: 10.1161/01.cir.97.1.66. View

17.

Abrams J, Epstein A, Freedman R, Hayes D, Hlatky M, Kerber R . ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE.... Circulation. 2002; 106(16):2145-61. DOI: 10.1161/01.cir.0000035996.46455.09. View

18.

Wathen M, Sweeney M, DeGroot P, Stark A, Koehler J, Chisner M . Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease. Circulation. 2001; 104(7):796-801. DOI: 10.1161/hc3101.093906. View

19.

Julian D, Camm A, Frangin G, Janse M, Munoz A, Schwartz P . Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators. Lancet. 1997; 349(9053):667-74. DOI: 10.1016/s0140-6736(96)09145-3. View

20.

Stanton M, Bell G . Economic outcomes of implantable cardioverter-defibrillators. Circulation. 2000; 101(9):1067-74. DOI: 10.1161/01.cir.101.9.1067. View